Mo Farah stands by coach Alberto Salazar despite allegations of doping

Farah believes evidence given by Salazar

Alberto Salazar, left, watches (from left) Cam Levins, Mo Farah and Galen Rupp as they train at the Nike Oregon Project in 2013
Alberto Salazar, left, watches (from left) Cam Levins, Mo Farah and Galen Rupp as they train at the Nike Oregon Project in 2013

Mo Farah has given his backing to coach Alberto Salazar and will continue training under him following his response to doping allegations.

The British double Olympic champion says he believes in the evidence provided by Salazar and will continue to work with him.

Salazar issued a lengthy rebuttal of almost 12,000 words denying the claims made by BBC Panorama and US investigative website ProPublica that he violated several anti-doping rules, including using testosterone medication on Farah's training partner Galen Rupp when he was 16 in 2002.

Farah said in a statement: "Following all the speculation I want to make it clear where I stand. Although it's been a difficult time, I asked Alberto to respond to the allegations made against him and he has now done so in full.

"As someone I've worked with for many years, I feel I have to believe in Alberto and the evidence he has provided. Based on that evidence, I will continue to work with him and hope now that I can focus on what I do best - training hard to win medals for my country."

Farah is expected to return to the track on July 9 for the first time since the allegations broke. Organisers of the Diamond League meeting say Farah will compete in the 5,000 metres. He is also due to run in the Diamond League meeting in Monaco on July 17.

Meanwhile, Rupp has insisted he is "100 per cent" behind Salazar following the doping allegations.

Rupp, who won silver behind Farah in the 10,000m at the London 2012 Olympics, said he believed in "clean sport".

"I think the truth will prevail. I stand behind him [Salazar] 100 per cent," Rupp said in quotes on NBC Sports' official website. "I believe in clean sport."

The allegations against Salazar included a claim by United States distance runner Kara Goucher that in 2011 he recommended she take the thyroid medication Cytomel in order to lose weight.

In his response, Salazar insisted he had never criticised Goucher's weight and that Goucher's own endocrinologist had directed him to give her Cytomel.

Goucher responded on Friday saying she and her husband Adam had approached the US Anti-Doping Agency (USADA) with their concerns.

She said on Twitter: "Unfortunately, Alberto's false statements and one-sided, partial stories don't tell the truth. Adam and I went to USADA in February 2013 when we had concerns about what we had experienced at the Oregon Project."

USADA is reportedly still investigating the case.

PA

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in